$14.41
+1.14 (+8.59%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+71.1% upside
Low Target
$19.75
Average Target
$24.65
High Target
$31.92
Current Price
$14.41
Current
$14.41
$14.41
Target
$24.65
$24.65
$19.75
$24.65 avg
$31.92
Scenario Analysis
Bear Case
$19.75
37.1%
Low target
Base Case
$24.65
+71.1%
Avg target
Bull Case
$31.92
+121.5%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$24.28
-40.7% from high
52-Week Low
$2.11
+584.6% from low
50-Day SMA
$15.08
-4.4% vs SMA
200-Day SMA
$15.11
-4.6% vs SMA
RSI (14)
55.2
Neutral
Target vs 52W High
$24.65
+1.5% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.13
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |